This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Westaby, S. Articles by Jarvik, R. Search for Related Content PubMed PubMed Citation Articles by Westaby, S. Articles by Jarvik, R. Pubmed/NCBI databases Medline Plus Health Information Heart Diseases

(Circulation. 1998;98:1568-1574.)
© 1998 American Heart Association, Inc.

Basic Science Reports

Jarvik 2000 Heart

Potential for Bridge to Myocyte Recovery

Stephen Westaby, MS, FRCS; Takahiro Katsumata, MD, PhD; Remi Houel, MD; Rhys Evans, MD; David Pigott, MD; O. H. Frazier, MD; ; Robert Jarvik, MD

From the Oxford Heart Centre (S.W., T.K., R.H., R.E., D.P.), Oxford, UK; the Texas Heart Institute (O.H.F.), Houston, Tex, and Jarvik Heart, Inc (R.J.), New York, NY.

Correspondence to Stephen Westaby, MS, FRCS, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.

Background—Mechanical bridge to left ventricular recovery is an emerging strategy for the treatment of heart failure. We sought to validate the use of a new intracardiac axial flow impeller pump for this purpose.

Methods and Results—The Jarvik 2000 Heart was implanted into 30 sheep to ascertain mechanical reliability, biocompatibility, and hemodynamic function. We attempted but failed to anticoagulate with warfarin. Elective explants with survival were performed in 3 animals to simulate bridge to recovery. Extensive autopsy studies were performed in all other animals. At speeds between 8000 and 12 000 rpm the device pumped up to 8 L/min, captured all mitral flow, and augmented cardiac output with elevation of mean arterial pressure. The pump was silent and hemolysis negligible. Nonpulsatile flow did not adversely affect neurological or renal function. Device removal proved straightforward and safe. A fractured inflow bearing occurred in 1 early model. There were no other pump failures, but power interruption occurred when the sheep chewed the cables or head-butted the percutaneous pedestal. At autopsy, there was no thromboembolism or primary thrombus formation in any device. Pump occlusion occurred in 2 sheep with bacterial endocarditis. One electively explanted pump, previously switched off for 5 months, had no thrombus in the device or vascular graft.

Conclusions—The Jarvik 2000 Heart is a major advance in blood-pump technology and increases the scope of mechanical circulatory support. Reliability and ease of removal favor its use for bridge to myocyte recovery, as well as for bridge to transplantation or long-term support.

Key Words: heart failure • myocytes • Jarvik 2000 • heart-assist device

This article has been cited by other articles:

				R. Ibuki, S. Maruyama, A. Komiya, and T. Yambe Design of Plate-type Actuator using SMA Wire for Assistant Artificial Heart Muscle Journal of Intelligent Material Systems and Structures, March 1, 2008; 19(3): 359 - 365. [Abstract] [PDF]

				O. H. Frazier, T. J. Myers, S. Westaby, and I. D. Gregoric Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection Ann. Thorac. Surg., January 1, 2004; 77(1): 133 - 142. [Abstract] [Full Text] [PDF]

				N. A. Nussmeier, C. B. Probert, D. Hirsch, J. R. Cooper Jr., I. D. Gregoric, T. J. Myers, and O. H. Frazier Anesthetic Management for Implantation of the Jarvik 2000TM Left Ventricular Assist System Anesth. Analg., October 1, 2003; 97(4): 964 - 971. [Abstract] [Full Text] [PDF]

				S. Westaby, O.H. Frazier, F. Beyersdorf, S. Saito, M. P. Siegenthaler, D. W. Pigott, P. A. Catarino, and R. Jarvik The Jarvik 2000 Heart. Clinical validation of the intraventricular position Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 228 - 232. [Abstract] [Full Text] [PDF]

				T. A. Snyder, M. J. Watach, K. N. Litwak, and W. R. Wagner Platelet activation, aggregation, and life span in calves implanted with axial flow ventricular assist devices Ann. Thorac. Surg., June 1, 2002; 73(6): 1933 - 1938. [Abstract] [Full Text] [PDF]

				S. Westaby, R. Jarvik, A. Freeland, D. Pigott, D. Robson, S. Saito, P. Catarino, and O. H. Frazier Postauricular percutaneous power delivery for permanent mechanical circulatory support J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 977 - 983. [Abstract] [Full Text] [PDF]

				S. Westaby, O.H. Frazier, D. W. Pigott, S. Saito, and R. K. Jarvik Implant technique for the Jarvik 2000 heart Ann. Thorac. Surg., April 1, 2002; 73(4): 1337 - 1340. [Abstract] [Full Text] [PDF]

				O.H. Frazier, T. J. Myers, R. K. Jarvik, S. Westaby, D. W. Pigott, I. D. Gregoric, T. Khan, D. W. Tamez, J. L. Conger, and M. P. Macris Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart Ann. Thorac. Surg., March 1, 2001; 71 (2007): S125 - S132. [Abstract] [Full Text] [PDF]

				S. Westaby, T. Katsumata, D. Pigott, X. Y. Jin, K. Saatvedt, M. Horton, and R. E. Clark Mechanical bridge to recovery in fulminant myocarditis Ann. Thorac. Surg., July 1, 2000; 70(1): 278 - 282. [Abstract] [Full Text] [PDF]

				S. Westaby HEART FAILURE: Non-transplant surgery for heart failure Heart, May 1, 2000; 83(5): 603 - 603. [Full Text]

				S Westaby, O Franklin, and M Burch New developments in the treatment of cardiac failure Arch. Dis. Child., September 1, 1999; 81(3): 276 - 277. [Full Text]